Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Late HIV presentation: epidemiology, clinical implications and management.

Waters L, Sabin CA.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):877-89. doi: 10.1586/eri.11.106. Review.

PMID:
21973300
2.

[Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].

Miró JM, Manzardo C, Zamora L, Pumarola T, Herreras Z, Gallart T, Gatell JM.

Enferm Infecc Microbiol Clin. 2011 Dec;29(10):759-72. doi: 10.1016/j.eimc.2011.10.009. Epub 2011 Nov 10. Review. Spanish.

PMID:
22078726
3.

Late presentation of HIV-infected individuals.

Battegay M, Fluckiger U, Hirschel B, Furrer H.

Antivir Ther. 2007;12(6):841-51. Review.

PMID:
17926639
4.

Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.

Celesia BM, Castronuovo D, Pinzone MR, Bellissimo F, Mughini MT, Lupo G, Scarpino MR, Gussio M, Palermo F, Cosentino S, Cacopardo B, Nunnari G.

Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2218-24.

5.

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care.

Sobrino-Vegas P, Rodríguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, Moreno S, Bernardino I, del Amo J; CoRIS.

Antivir Ther. 2012;17(1):1-8. doi: 10.3851/IMP1939.

PMID:
22267463
6.

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3.

7.

Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.

Sühs KW, Stoll M, Diem R, Schmidt RE, Heiken H.

Arch Virol. 2012 Mar;157(3):433-40. doi: 10.1007/s00705-011-1191-9. Epub 2011 Dec 18.

PMID:
22179846
8.

Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre.

Yombi JC, Jonckheere S, Vincent A, Wilmes D, Vandercam B, Belkhir L.

Acta Clin Belg. 2014 Jan-Feb;69(1):33-9. doi: 10.1179/0001551213Z.00000000014.

PMID:
24635397
9.

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997.

Binquet C, Chêne G, Jacqmin-Gadda H, Journot V, Savès M, Lacoste D, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Am J Epidemiol. 2001 Feb 15;153(4):386-93.

PMID:
11207157
10.

Discordant responses to cART in HIV-1 patients in the era of high potency antiretroviral drugs: clinical evaluation, classification, management prospects.

Cenderello G, De Maria A.

Expert Rev Anti Infect Ther. 2016;14(1):29-40. doi: 10.1586/14787210.2016.1106937. Epub 2015 Oct 29. Review.

PMID:
26513236
11.

Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.

Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, Ward J.

MMWR CDC Surveill Summ. 1999 Apr 16;48(2):1-22.

PMID:
12412613
12.

Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.

Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Klein MB; CANOC Collaboration.

PLoS One. 2013 Oct 30;8(10):e77665. doi: 10.1371/journal.pone.0077665. eCollection 2013.

13.

Poor functional immune recovery in aged HIV-1-infected patients following successfully treatment with antiretroviral therapy.

Kasahara TM, Hygino J, Andrade RM, Monteiro C, Sacramento PM, Andrade AF, Bento CA.

Hum Immunol. 2015 Oct;76(10):701-10. doi: 10.1016/j.humimm.2015.09.023. Epub 2015 Sep 30.

PMID:
26429325
14.

Mutation and control of the human immunodeficiency virus.

Stengel RF.

Math Biosci. 2008 Jun;213(2):93-102. doi: 10.1016/j.mbs.2008.03.002. Epub 2008 Mar 20.

PMID:
18439629
15.

Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease.

Soria A, Lazzarin A.

J Acquir Immune Defic Syndr. 2007 Sep;46 Suppl 1:S19-30. Review.

PMID:
17713422
16.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
17.

[Immunologic and viral mechanisms implicated in HIV infection: the impact of treatment].

Delfraissy JF.

Rev Prat. 1999 Oct 15;49(16):1740-5. French.

PMID:
10578603
18.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for the Treatment of HIV.

MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55.

19.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
20.

Therapies. Confronting the limits of success.

Cohen J.

Science. 2002 Jun 28;296(5577):2320-4. No abstract available.

PMID:
12089422

Supplemental Content

Support Center